vs

Side-by-side financial comparison of Capitol Federal Financial, Inc. (CFFN) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $56.8M, roughly 1.3× Capitol Federal Financial, Inc.). On growth, Capitol Federal Financial, Inc. posted the faster year-over-year revenue change (21.0% vs -36.9%). Capitol Federal Financial, Inc. produced more free cash flow last quarter ($15.8M vs $-6.6M). Over the past eight quarters, Capitol Federal Financial, Inc.'s revenue compounded faster (36.0% CAGR vs -34.4%).

Capitol Federal Savings Bank (CapFed) is a federally chartered and insured savings bank founded in 1893 and headquartered in Topeka, Kansas. Capitol Federal has 51 locations serving both the Kansas and Missouri sides of the Kansas City metropolitan area with personal and business financial services. It is owned by holding company Capitol Federal Financial Inc. for trading on the Nasdaq.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

CFFN vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.3× larger
MED
$75.1M
$56.8M
CFFN
Growing faster (revenue YoY)
CFFN
CFFN
+57.9% gap
CFFN
21.0%
-36.9%
MED
More free cash flow
CFFN
CFFN
$22.5M more FCF
CFFN
$15.8M
$-6.6M
MED
Faster 2-yr revenue CAGR
CFFN
CFFN
Annualised
CFFN
36.0%
-34.4%
MED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CFFN
CFFN
MED
MED
Revenue
$56.8M
$75.1M
Net Profit
$20.3M
Gross Margin
69.4%
Operating Margin
44.4%
-10.4%
Net Margin
35.7%
Revenue YoY
21.0%
-36.9%
Net Profit YoY
31.6%
EPS (diluted)
$0.16
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFFN
CFFN
MED
MED
Q4 25
$56.8M
$75.1M
Q3 25
$54.6M
$89.4M
Q2 25
$50.7M
$105.6M
Q1 25
$48.8M
$115.7M
Q4 24
$46.9M
$119.0M
Q3 24
$140.2M
Q2 24
$45.0M
$168.6M
Q1 24
$46.0M
$174.7M
Net Profit
CFFN
CFFN
MED
MED
Q4 25
$20.3M
Q3 25
$18.8M
$-2.3M
Q2 25
$18.4M
$2.5M
Q1 25
$15.4M
$-772.0K
Q4 24
$15.4M
Q3 24
$1.1M
Q2 24
$9.6M
$-8.2M
Q1 24
$13.8M
$8.3M
Gross Margin
CFFN
CFFN
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
CFFN
CFFN
MED
MED
Q4 25
44.4%
-10.4%
Q3 25
42.2%
-4.6%
Q2 25
42.6%
-1.0%
Q1 25
39.5%
-1.1%
Q4 24
40.7%
0.6%
Q3 24
1.5%
Q2 24
34.7%
-4.7%
Q1 24
37.5%
4.5%
Net Margin
CFFN
CFFN
MED
MED
Q4 25
35.7%
Q3 25
34.5%
-2.5%
Q2 25
36.2%
2.3%
Q1 25
31.6%
-0.7%
Q4 24
32.9%
Q3 24
0.8%
Q2 24
21.4%
-4.8%
Q1 24
29.9%
4.8%
EPS (diluted)
CFFN
CFFN
MED
MED
Q4 25
$0.16
$-1.64
Q3 25
$0.14
$-0.21
Q2 25
$0.14
$0.22
Q1 25
$0.12
$-0.07
Q4 24
$0.12
$0.08
Q3 24
$0.10
Q2 24
$0.07
$-0.75
Q1 24
$0.11
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFFN
CFFN
MED
MED
Cash + ST InvestmentsLiquidity on hand
$232.6M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.0B
$198.9M
Total Assets
$9.8B
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFFN
CFFN
MED
MED
Q4 25
$232.6M
$167.3M
Q3 25
$252.4M
$173.5M
Q2 25
$175.0M
$162.7M
Q1 25
$340.4M
$164.6M
Q4 24
$170.3M
$162.3M
Q3 24
$170.0M
Q2 24
$317.8M
$163.5M
Q1 24
$443.5M
$156.4M
Stockholders' Equity
CFFN
CFFN
MED
MED
Q4 25
$1.0B
$198.9M
Q3 25
$1.0B
$214.7M
Q2 25
$1.0B
$216.0M
Q1 25
$1.0B
$211.0M
Q4 24
$1.0B
$210.1M
Q3 24
$207.3M
Q2 24
$1.0B
$205.3M
Q1 24
$1.0B
$211.0M
Total Assets
CFFN
CFFN
MED
MED
Q4 25
$9.8B
$248.0M
Q3 25
$9.8B
$268.2M
Q2 25
$9.7B
$269.3M
Q1 25
$9.7B
$280.0M
Q4 24
$9.5B
$284.2M
Q3 24
$291.2M
Q2 24
$9.6B
$293.5M
Q1 24
$9.7B
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CFFN
CFFN
MED
MED
Operating Cash FlowLast quarter
$17.4M
$-5.3M
Free Cash FlowOCF − Capex
$15.8M
$-6.6M
FCF MarginFCF / Revenue
27.9%
-8.8%
Capex IntensityCapex / Revenue
2.8%
1.8%
Cash ConversionOCF / Net Profit
0.86×
TTM Free Cash FlowTrailing 4 quarters
$91.2M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CFFN
CFFN
MED
MED
Q4 25
$17.4M
$-5.3M
Q3 25
$55.0M
$12.1M
Q2 25
$12.4M
$-3.4M
Q1 25
$15.5M
$3.4M
Q4 24
$5.6M
$-4.9M
Q3 24
$9.1M
Q2 24
$19.1M
$13.1M
Q1 24
$20.5M
$7.3M
Free Cash Flow
CFFN
CFFN
MED
MED
Q4 25
$15.8M
$-6.6M
Q3 25
$49.8M
$10.8M
Q2 25
$10.8M
$-4.8M
Q1 25
$14.7M
$1.9M
Q4 24
$4.5M
$-7.2M
Q3 24
$7.7M
Q2 24
$16.4M
$11.1M
Q1 24
$19.0M
$5.4M
FCF Margin
CFFN
CFFN
MED
MED
Q4 25
27.9%
-8.8%
Q3 25
91.3%
12.0%
Q2 25
21.2%
-4.5%
Q1 25
30.2%
1.6%
Q4 24
9.5%
-6.1%
Q3 24
5.5%
Q2 24
36.5%
6.6%
Q1 24
41.4%
3.1%
Capex Intensity
CFFN
CFFN
MED
MED
Q4 25
2.8%
1.8%
Q3 25
9.5%
1.5%
Q2 25
3.2%
1.3%
Q1 25
1.5%
1.3%
Q4 24
2.5%
1.9%
Q3 24
1.0%
Q2 24
5.9%
1.1%
Q1 24
3.2%
1.1%
Cash Conversion
CFFN
CFFN
MED
MED
Q4 25
0.86×
Q3 25
2.93×
Q2 25
0.67×
-1.36×
Q1 25
1.01×
Q4 24
0.36×
Q3 24
8.04×
Q2 24
1.98×
Q1 24
1.49×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons